Literature DB >> 16504877

Surgery for primary pancreatic neuroendocrine tumors.

Jeffrey A Norton1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16504877     DOI： 10.1016/j.gassur.2005.08.023

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  18 in total

1.  Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).

Authors:  G Cadiot; A Vuagnat; I Doukhan; A Murat; G Bonnaud; B Delemer; G Thiéfin; A Beckers; M Veyrac; C Proye; P Ruszniewski; M Mignon
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

2.  Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study.

Authors:  B C Sheppard; J A Norton; J L Doppman; P N Maton; J D Gardner; R T Jensen
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

3.  The surgical treatment of gastrinoma in MEN I syndrome patients.

Authors:  N W Thompson; A G Bondeson; L Bondeson; A Vinik
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

Review 4.  Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1.

Authors:  P Chanson; G Cadiot; A Murat
Journal:  Horm Res       Date:  1997

5.  Surgery to cure the Zollinger-Ellison syndrome.

Authors:  J A Norton; D L Fraker; H R Alexander; D J Venzon; J L Doppman; J Serrano; S U Goebel; P L Peghini; P K Roy; F Gibril; R T Jensen
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

6.  Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.

Authors:  F Gibril; J C Reynolds; J L Doppman; C C Chen; D J Venzon; B Termanini; H C Weber; C A Stewart; R T Jensen
Journal:  Ann Intern Med       Date:  1996-07-01       Impact factor: 25.391

7.  Clinicopathological characteristics of duodenal microgastrinomas.

Authors:  M Imamura; M Kanda; K Takahashi; Y Shimada; T Miyahara; T Wagata; M Hashimoto; T Tobe; J Soga
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

8.  Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.

Authors:  Jeffrey A Norton; H Richard Alexander; Douglas L Fraker; David J Venzon; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

Authors:  P Ruszniewski; P Rougier; A Roche; P Legmann; A Sibert; S Hochlaf; M Ychou; M Mignon
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

Review 10.  Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome.

Authors:  R Delcore; S R Friesen
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982
View more
  16 in total

1.  Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases.

Authors:  Alessandro Zerbi; Vanessa Capitanio; Letizia Boninsegna; Claudio Pasquali; Guido Rindi; Gianfranco Delle Fave; Marco Del Chiaro; Riccardo Casadei; Massimo Falconi
Journal:  Langenbecks Arch Surg       Date:  2010-09-21       Impact factor: 3.445

2.  Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.

Authors:  David J Worhunsky; Geoffrey W Krampitz; Peter D Poullos; Brendan C Visser; Pamela L Kunz; George A Fisher; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 3.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  Laparoscopic enucleation of pancreatic neoplasm.

Authors:  A Dedieu; A Rault; D Collet; B Masson; A Sa Cunha
Journal:  Surg Endosc       Date:  2010-07-10       Impact factor: 4.584

Review 5.  Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.

Authors:  Tarun Rustagi; Mridula Rai; Frank Bauer
Journal:  J Gastrointest Cancer       Date:  2013-09

6.  Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.

Authors:  Joo Young Kim; Jacqueline A Brosnan-Cashman; Soyeon An; Sung Joo Kim; Ki-Byung Song; Min-Sun Kim; Mi-Ju Kim; Dae Wook Hwang; Alan K Meeker; Eunsil Yu; Song Cheol Kim; Ralph H Hruban; Christopher M Heaphy; Seung-Mo Hong
Journal:  Clin Cancer Res       Date:  2016-09-23       Impact factor: 12.531

7.  Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors.

Authors:  Kristin Heeger; Massimo Falconi; Stefano Partelli; Jens Waldmann; Stefano Crippa; Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2014-02-14       Impact factor: 3.445

8.  Enucleation of pancreatic cystadenomas.

Authors:  Chunlin Ge; Xiaoguang Luo; Xuchun Chen; Kejian Guo
Journal:  J Gastrointest Surg       Date:  2009-09-25       Impact factor: 3.452

9.  Enucleation of non-invasive tumors in the proximal pancreas: indications and outcomes compared with standard resections.

Authors:  Wen-Jie Lu; Hao-Lei Cai; Ma-Dong Ye; Yu-Lian Wu; Bin Xu
Journal:  J Zhejiang Univ Sci B       Date:  2017 Oct.       Impact factor: 3.066

10.  Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.

Authors:  Yuping Xu; Donghui Pan; Qing Xu; Chen Zhu; Lizhen Wang; Fei Chen; Runlin Yang; Shineng Luo; Min Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-17       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.